by Administrator | Jan 11, 2016 | 340B, blog, HIV Treatment
Curant’s Managing Director of Operations, Dave Cunnold, is featured in Managed Healthcare Executive providing insight on the evolution of the healthcare experience for patients with chronic conditions. The successful patient journey has evolved due to the transition...
by Administrator | Dec 22, 2015 | blog, HIV Treatment
Curant COO, Marc O’Connor, was recently featured in Specialty Pharmacy Times in a piece that highlights the futility of presidential candidates focusing strictly on pharmaceutical manufacturers as the primary source of healthcare’s woes. It is true that companies such...
by Administrator | Nov 23, 2015 | 340B, blog, HIV Treatment
Presenting with a CD4 count of only 21, doctors gave Robert W. mere months to live. Weighing only 98 pounds, his HIV had progressed to Stage 3 AIDS, and he was on his deathbed. Robert had been prescribed seven different HIV medications and had a long history of...
by Administrator | Nov 13, 2015 | blog, HIV Treatment
What are the new questions regarding HIV treatment? When it comes to hepatitis C, Gilead drugs Harvoni and Sovaldi have validated their value-based care. If faced with the options of spending $577,000 on a liver transplant or $94,500 on a course of Harvoni for...
by Administrator | Sep 29, 2015 | blog, HIV Treatment
We’ve talked about who we are: Curant Health is a team of healthcare experts who provide individualized, patient-centered services proven to deliver improved health outcomes. We’ve talked about what we bring to the healthcare table, including the improved outcomes...
Recent Comments